Valiloxybate
Valiloxybate (INNTooltip International Nonproprietary Name, USANTooltip United States Adopted Name; developmental code name XW-10172) is an extended-release prodrug of γ-hydroxybutyrate (GHB; oxybate) which is under development for the treatment of narcolepsy. It is also being investigated for treatment of excessive daytime sleepiness (EDS) in people with Parkinson's disease.